β blockers and statins in non-cardiac surgery

British Medical Journal

Volumn 334, Issue 7607, 2007, Pages 1283-1284

  Bolsin, Stephen ^a   Colson, Mark ^b   Conroy, Myles ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GEELONG HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR RISK; DIABETES MELLITUS; EDITORIAL; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SURGICAL PATIENT; HEART DISEASE; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION;

ADRENERGIC BETA-ANTAGONISTS; EVIDENCE-BASED MEDICINE; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTRAOPERATIVE CARE; INTRAOPERATIVE COMPLICATIONS;

EID: 34250824124     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39217.382836.BE     Document Type: Editorial

References (12)

1. Schouten O, Bax JJ, Poldermans D. Assessment of cardiac risk before non-cardiac general surgery. Heart 2006;92:1866-72.
2. Bolsin S, Colson M. β blockers for patients at risk of cardiac events during non-cardiac surgery. BMJ 2005;331:919-20.
3. Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005;118:1134-41.
4. Devereaux PJ, Beattie WS, Choi PT-L, Badner NH, Guyatt GH, Villar JC, et al. How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005;331:313-21.
5. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006;333. Epub 2006 Nov 6.
6. Mangano DT, Layug EL, Wallace A, Tateo I; Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-21.
7. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, et al. Effect of perioperative β blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006;332:1482.
8. Yang H, Raymer K, Butler R, Parlow I, Roberts R. The effects of perioperative β-blockade: results of the metoprolol aftervascular surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006;152:983-90.
9. Brady AR, Gibbs JSR, Greenhalgh RM, Powell JT, Sydes MR; POBBLE Trial Investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infra renal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg 2005;41:602-9.
10. McCullough PA. Failure of beta-blockers in the reduction of perioperative events: where did we go wrong? Am Heart J 2006;152:815-8.
11. Devereaux PJ, Yang H, Guyatt GH, Leslie K, Villar JC, Monteri VM, et al. Rationale, design, and organization of the perioperative ischemic evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 2006;152:223-30.
12. Schouten O, Kertai MD, Bax JJ, Durazzo AES, Biagini E, Boersma E, et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 2005;95:658-60.